Ellagic acid

Ellagic acid is an inhibitor of Topoisomerase used in studies of DNA Damage Response and Oxidative Stress Response. It is especially relevant in cancer, dna damage / repair, and oxidative stress models, where defined compound exposure can be linked to checkpoint activation, DNA repair, and genome-stability control and redox signaling, ROS handling, and antioxidant defenses.

By inhibiting Topoisomerase, Ellagic acid can be used to examine checkpoint activation, DNA repair, and genome-stability control and redox signaling, ROS handling, and antioxidant defenses. The enzyme annotation adds relevance to enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping in the same experimental setting. In cancer, dna damage / repair, and oxidative stress models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Topoisomerase
• Pathway perturbation studies connected to DNA Damage Response and Oxidative Stress Response
• Concentration-response inhibition and target-dependence studies
• Enzyme-activity assays, substrate-conversion studies, and mechanism profiling

Overall, Ellagic acid is appropriate when a defined chemical perturbant is needed to connect Topoisomerase with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, dna damage / repair, and oxidative stress models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.